Drug intelligence / Profile preview

cyclic diadenosine monophosphate

Development stage
Unknown
Lead developer
Helmholtz Centre for Infection Research
Modality
Small Molecules
Administration
Intramuscular, Intranasal, Intperitoneal, Subcutaneous
01

Overview

Cyclic diadenosine monophosphate (c-di-AMP) is a naturally occurring bacterial second messenger and cyclic dinucleotide that plays a critical role in prokaryotic physiology, including cell wall homeostasis, potassium transport, osmotic stress response, and DNA integrity. In mammalian hosts, c-di-AMP acts as a potent pathogen-associated molecular pattern (PAMP) that directly binds to and activates the Stimulator of Interferon Genes (STING) pathway, triggering a type I interferon response and activating innate immunity. Due to its ability to stimulate robust humoral and cellular immune responses, c-di-AMP is widely utilized as a research tool and is being investigated as a mucosal vaccine adjuvant and immunotherapeutic agent.

Other names
3',5'-cyclic di-adenosine monophosphate3',5'-cyclic diadenylic acidbis-(3',5')-cyclic diadenosine monophosphatebis-(3',5')-cyclic dimeric adenosine monophosphatec-di-AMPcyclic di-adenosine monophosphatecyclic di-adenylate monophosphatecyclic diadenylatecyclic diadenylate monophosphate
02

Targets

DDX41STING (Stimulator of interferon genes protein)

Beyond the preview

Go deeper on cyclic diadenosine monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclic diadenosine monophosphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call